Acanthopanax senticosus inhibits nitric oxide production in murine macrophages in vitro and in vivo. 2007

Qiu-Ye Lin, and Li-Ji Jin, and Yong-Sheng Ma, and Ming Shi, and Yong-Ping Xu
Department of Bioscience and Biotechnology, Dalian University of Technology, Dalian, People's Republic of China. qiuye.lin@gmail.com

Excess nitric oxide (NO) production has been implicated in inflammatory diseases. The present study investigated the inhibitory effect of the stem bark extract of Acanthopanax senticosus (A. senticosus) on NO production in murine macrophages in vitro and in vivo. In vitro exposure of RAW264.7 cells to 1, 10, 50, 100, 250, 500 and 1000 microg/mL of A. senticosus extract significantly suppressed NO production induced by lipopolysaccharide (LPS) and interferon gamma (IFN-gamma) in a dose-dependent manner. In vitro exposure of mouse resident peritoneal macrophages to 1, 10, 100 and 1000 microg/mL of A. senticosus extract significantly suppressed NO production induced by LPS and IFN-gamma in a dose-dependent manner. In vivo administration of A. senticosus extract (50, 100 and 200 mg/kg) to KM mice dose-dependently inhibited LPS and IFN-gamma induced production of NO in isolated mouse peritoneal macrophages ex vivo. Exposure to A. senticosus extract had no effect on cell viability and systemic toxicity. The results demonstrated that the stem bark extract of A. senticosus extract inhibits NO production in murine macrophages in vitro and in vivo.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008517 Phytotherapy Use of plants or herbs to treat diseases or to alleviate pain. Herb Therapy,Herbal Therapy
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Qiu-Ye Lin, and Li-Ji Jin, and Yong-Sheng Ma, and Ming Shi, and Yong-Ping Xu
May 1995, Toxicology and applied pharmacology,
Qiu-Ye Lin, and Li-Ji Jin, and Yong-Sheng Ma, and Ming Shi, and Yong-Ping Xu
March 1996, Journal of leukocyte biology,
Qiu-Ye Lin, and Li-Ji Jin, and Yong-Sheng Ma, and Ming Shi, and Yong-Ping Xu
April 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Qiu-Ye Lin, and Li-Ji Jin, and Yong-Sheng Ma, and Ming Shi, and Yong-Ping Xu
January 2002, Experimental parasitology,
Qiu-Ye Lin, and Li-Ji Jin, and Yong-Sheng Ma, and Ming Shi, and Yong-Ping Xu
August 1998, Journal of neuroimmunology,
Qiu-Ye Lin, and Li-Ji Jin, and Yong-Sheng Ma, and Ming Shi, and Yong-Ping Xu
September 2019, Planta medica,
Qiu-Ye Lin, and Li-Ji Jin, and Yong-Sheng Ma, and Ming Shi, and Yong-Ping Xu
February 2001, Journal of ethnopharmacology,
Qiu-Ye Lin, and Li-Ji Jin, and Yong-Sheng Ma, and Ming Shi, and Yong-Ping Xu
January 2010, Journal of biomedicine & biotechnology,
Qiu-Ye Lin, and Li-Ji Jin, and Yong-Sheng Ma, and Ming Shi, and Yong-Ping Xu
March 2000, International journal of immunopharmacology,
Qiu-Ye Lin, and Li-Ji Jin, and Yong-Sheng Ma, and Ming Shi, and Yong-Ping Xu
April 1998, Infection and immunity,
Copied contents to your clipboard!